Christoph Plass - Publications

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
Molecular Biology, Oncology

149 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Schmidt-Wolf IG, Plass C, Byrd JC, Frevel K, Pietsch T, Waha A. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL. Anticancer Research. 36: 4515-9. PMID 27630290  0.4
2016 Trump S, Bieg M, Gu Z, Thürmann L, Bauer T, Bauer M, Ishaque N, Röder S, Gu L, Herberth G, Lawerenz C, Borte M, Schlesner M, Plass C, Diessl N, et al. Prenatal maternal stress and wheeze in children: novel insights into epigenetic regulation. Scientific Reports. 6: 28616. PMID 27349968 DOI: 10.1038/srep28616  0.4
2016 Chen TL, Gupta N, Lehman A, Ruppert AS, Yu L, Oakes CC, Claus R, Plass C, Maddocks KJ, Andritsos L, Jones JA, Lucas DM, Johnson AJ, Byrd JC, Hertlein E. Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia. Oncotarget. PMID 27107422 DOI: 10.18632/oncotarget.8760  0.4
2016 Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, Wang Q, Imbusch CD, Serva A, Koser SD, Brocks D, Lipka DB, Bogatyrova O, Weichenhan D, Brors B, ... ... Plass C, et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nature Genetics. PMID 26780610 DOI: 10.1038/ng.3488  0.4
2015 Junge KM, Bauer T, Geissler S, Hirche F, Thürmann L, Bauer M, Trump S, Bieg M, Weichenhan D, Gu L, Mallm JP, Ishaque N, Mücke O, Röder S, Herberth G, ... ... Plass C, et al. Increased vitamin D levels at birth and in early infancy increase offspring allergy risk-evidence for involvement of epigenetic mechanisms. The Journal of Allergy and Clinical Immunology. PMID 26282283 DOI: 10.1016/j.jaci.2015.06.040  0.4
2015 Varagnolo L, Lin Q, Obier N, Plass C, Dietl J, Zenke M, Claus R, Müller AM. PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells. Scientific Reports. 5: 12319. PMID 26198814 DOI: 10.1038/srep12319  0.4
2015 Schramm A, Köster J, Assenov Y, Althoff K, Peifer M, Mahlow E, Odersky A, Beisser D, Ernst C, Henssen AG, Stephan H, Schröder C, Heukamp L, Engesser A, Kahlert Y, ... ... Plass C, et al. Mutational dynamics between primary and relapse neuroblastomas. Nature Genetics. PMID 26121086 DOI: 10.1038/ng.3349  0.4
2015 Campos B, Weisang S, Osswald F, Ali R, Sedlmeier G, Bageritz J, Mallm JP, Hartmann C, von Deimling A, Popanda O, Goidts V, Plass C, Unterberg A, Schmezer P, Burhenne J, et al. Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma. Glia. PMID 25944104 DOI: 10.1002/glia.22849  0.4
2015 Merkel O, Hamacher F, Griessl R, Grabner L, Schiefer AI, Prutsch N, Baer C, Egger G, Schlederer M, Krenn PW, Hartmann TN, Simonitsch-Klupp I, Plass C, Staber PB, Moriggl R, et al. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation. The Journal of Pathology. PMID 25820993 DOI: 10.1002/path.4539  0.4
2015 Lucas DM, Ruppert AS, Lozanski G, Dewald GW, Lozanski A, Claus R, Plass C, Flinn IW, Neuberg DS, Paietta EM, Bennett JM, Jelinek DF, Gribben JG, Hussein MA, Appelbaum FR, et al. Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997. Leukemia & Lymphoma. 1-7. PMID 25721902 DOI: 10.3109/10428194.2015.1023800  0.4
2015 Baer C, Oakes CC, Ruppert AS, Claus R, Kim-Wanner SZ, Mertens D, Zenz T, Stilgenbauer S, Byrd JC, Plass C. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia. International Journal of Cancer. Journal International Du Cancer. 137: 1352-61. PMID 25704289 DOI: 10.1002/ijc.29491  0.4
2015 McGraw S, Zhang JX, Farag M, Chan D, Caron M, Konermann C, Oakes CC, Mohan KN, Plass C, Pastinen T, Bourque G, Chaillet JR, Trasler JM. Transient DNMT1 suppression reveals hidden heritable marks in the genome. Nucleic Acids Research. 43: 1485-97. PMID 25578964 DOI: 10.1093/nar/gku1386  0.4
2015 Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M, ... ... Plass C, et al. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nature Genetics. 47: 22-30. PMID 25485837 DOI: 10.1038/ng.3165  0.4
2015 Yang R, Pfütze K, Zucknick M, Sutter C, Wappenschmidt B, Marme F, Qu B, Cuk K, Engel C, Schott S, Schneeweiss A, Brenner H, Claus R, Plass C, Bugert P, et al. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood. International Journal of Cancer. Journal International Du Cancer. 136: 1845-55. PMID 25213452 DOI: 10.1002/ijc.29205  0.4
2014 Gaedcke J, Leha A, Claus R, Weichenhan D, Jung K, Kitz J, Grade M, Wolff HA, Jo P, Doyen J, Gérard JP, Johnsen SA, Plass C, Beißbarth T, Ghadimi M. Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer. Oncotarget. 5: 8123-35. PMID 25261372  0.4
2014 Cabezas-Wallscheid N, Klimmeck D, Hansson J, Lipka DB, Reyes A, Wang Q, Weichenhan D, Lier A, von Paleske L, Renders S, Wünsche P, Zeisberger P, Brocks D, Gu L, Herrmann C, ... ... Plass C, et al. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell. 15: 507-22. PMID 25158935 DOI: 10.1016/j.stem.2014.07.005  0.4
2014 Poetsch AR, Lipka DB, Witte T, Claus R, Nöllke P, Zucknick M, Olk-Batz C, Fluhr S, Dworzak M, De Moerloose B, Starý J, Zecca M, Hasle H, Schmugge M, van den Heuvel-Eibrink MM, ... ... Plass C, et al. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics : Official Journal of the Dna Methylation Society. 9: 1252-60. PMID 25147919 DOI: 10.4161/epi.29941  0.4
2014 Arab K, Park YJ, Lindroth AM, Schäfer A, Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, Dienemann H, Dyckhoff G, Herold-Mende C, Grummt I, Niehrs C, ... Plass C, et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Molecular Cell. 55: 604-14. PMID 25087872 DOI: 10.1016/j.molcel.2014.06.031  0.4
2014 Brocks D, Assenov Y, Minner S, Bogatyrova O, Simon R, Koop C, Oakes C, Zucknick M, Lipka DB, Weischenfeldt J, Feuerbach L, Cowper-Sal Lari R, Lupien M, Brors B, Korbel J, ... ... Plass C, et al. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Reports. 8: 798-806. PMID 25066126 DOI: 10.1016/j.celrep.2014.06.053  0.4
2014 Steurer S, Mayer PS, Adam M, Krohn A, Koop C, Ospina-Klinck D, Tehrani AA, Simon R, Tennstedt P, Graefen M, Wittmer C, Brors B, Plass C, Korbel J, Weischenfeldt J, et al. TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer. European Urology. 66: 978-81. PMID 25015038 DOI: 10.1016/j.eururo.2014.06.027  0.4
2014 Sonnet M, Claus R, Becker N, Zucknick M, Petersen J, Lipka DB, Oakes CC, Andrulis M, Lier A, Milsom MD, Witte T, Gu L, Kim-Wanner SZ, Schirmacher P, Wulfert M, ... ... Plass C, et al. Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia. Genome Medicine. 6: 34. PMID 24944583 DOI: 10.1186/gm551  0.4
2014 Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G. MGMT testing--the challenges for biomarker-based glioma treatment. Nature Reviews. Neurology. 10: 372-85. PMID 24912512 DOI: 10.1038/nrneurol.2014.100  0.4
2014 Claus R, Lucas DM, Ruppert AS, Williams KE, Weng D, Patterson K, Zucknick M, Oakes CC, Rassenti LZ, Greaves AW, Geyer S, Wierda WG, Brown JR, Gribben JG, Barrientos JC, ... ... Plass C, et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood. 124: 42-8. PMID 24868078 DOI: 10.1182/blood-2014-02-555722  0.4
2014 Warta R, Herold-Mende C, Chaisaingmongkol J, Popanda O, Mock A, Mogler C, Osswald F, Herpel E, Küstner S, Eckstein V, Plass C, Plinkert P, Schmezer P, Dyckhoff G. Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients. International Journal of Cancer. Journal International Du Cancer. 135: 2727-34. PMID 24740185 DOI: 10.1002/ijc.28906  0.4
2014 Song S, Walter V, Karaca M, Li Y, Bartlett CS, Smiraglia DJ, Serber D, Sproul CD, Plass C, Zhang J, Hayes DN, Zheng Y, Weissman BE. Gene silencing associated with SWI/SNF complex loss during NSCLC development. Molecular Cancer Research : McR. 12: 560-70. PMID 24445599 DOI: 10.1158/1541-7786.MCR-13-0427  0.4
2014 Marcucci G, Yan P, Maharry K, Frankhouser D, Nicolet D, Metzeler KH, Kohlschmidt J, Mrózek K, Wu YZ, Bucci D, Curfman JP, Whitman SP, Eisfeld AK, Mendler JH, Schwind S, ... ... Plass C, et al. Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 548-56. PMID 24378410 DOI: 10.1200/JCO.2013.50.6337  0.4
2014 Oakes CC, Claus R, Gu L, Assenov Y, Hüllein J, Zucknick M, Bieg M, Brocks D, Bogatyrova O, Schmidt CR, Rassenti L, Kipps TJ, Mertens D, Lichter P, Döhner H, ... ... Plass C, et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discovery. 4: 348-61. PMID 24356097 DOI: 10.1158/2159-8290.CD-13-0349  0.4
2014 Kuhmann C, Li C, Kloor M, Salou M, Weigel C, Schmidt CR, Ng LW, Tsui WW, Leung SY, Yuen ST, Becker N, Weichenhan D, Plass C, Schmezer P, Chan TL, et al. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer. Human Molecular Genetics. 23: 2043-54. PMID 24282031 DOI: 10.1093/hmg/ddt599  0.4
2014 Goeppert B, Konermann C, Schmidt CR, Bogatyrova O, Geiselhart L, Ernst C, Gu L, Becker N, Zucknick M, Mehrabi A, Hafezi M, Klauschen F, Stenzinger A, Warth A, Breuhahn K, ... ... Plass C, et al. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. Hepatology (Baltimore, Md.). 59: 544-54. PMID 24002901 DOI: 10.1002/hep.26721  0.4
2014 Dutruel C, Bergmann F, Rooman I, Zucknick M, Weichenhan D, Geiselhart L, Kaffenberger T, Rachakonda PS, Bauer A, Giese N, Hong C, Xie H, Costello JF, Hoheisel J, Kumar R, ... ... Plass C, et al. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development. Oncogene. 33: 3401-10. PMID 23912455 DOI: 10.1038/onc.2013.312  0.4
2013 McGraw S, Oakes CC, Martel J, Cirio MC, de Zeeuw P, Mak W, Plass C, Bartolomei MS, Chaillet JR, Trasler JM. Loss of DNMT1o disrupts imprinted X chromosome inactivation and accentuates placental defects in females. Plos Genetics. 9: e1003873. PMID 24278026 DOI: 10.1371/journal.pgen.1003873  0.4
2013 Banzhaf-Strathmann J, Claus R, Mücke O, Rentzsch K, van der Zee J, Engelborghs S, De Deyn PP, Cruts M, van Broeckhoven C, Plass C, Edbauer D. Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathologica Communications. 1: 16. PMID 24252647 DOI: 10.1186/2051-5960-1-16  0.4
2013 Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT, Kool M, Zapatka M, Northcott PA, Sturm D, Wang W, Radlwimmer B, Højfeldt JW, Truffaux N, Castel D, Schubert S, ... ... Plass C, et al. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell. 24: 660-72. PMID 24183680 DOI: 10.1016/j.ccr.2013.10.006  0.4
2013 Jäger N, Schlesner M, Jones DT, Raffel S, Mallm JP, Junge KM, Weichenhan D, Bauer T, Ishaque N, Kool M, Northcott PA, Korshunov A, Drews RM, Koster J, Versteeg R, ... ... Plass C, et al. Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell. 155: 567-81. PMID 24139898 DOI: 10.1016/j.cell.2013.09.042  0.4
2013 Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R, Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nature Reviews. Genetics. 14: 765-80. PMID 24105274 DOI: 10.1038/nrg3554  0.4
2013 Wang Q, Gu L, Adey A, Radlwimmer B, Wang W, Hovestadt V, Bähr M, Wolf S, Shendure J, Eils R, Plass C, Weichenhan D. Tagmentation-based whole-genome bisulfite sequencing. Nature Protocols. 8: 2022-32. PMID 24071908 DOI: 10.1038/nprot.2013.118  0.4
2013 Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AH, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, ... ... Plass C, et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nature Medicine. 19: 901-8. PMID 23793099 DOI: 10.1038/nm.3217  0.4
2013 Wiestler B, Claus R, Hartlieb SA, Schliesser MG, Weiss EK, Hielscher T, Platten M, Dittmann LM, Meisner C, Felsberg J, Happold C, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, ... ... Plass C, et al. Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology. 15: 1017-26. PMID 23595628 DOI: 10.1093/neuonc/not043  0.4
2013 Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K, Idler I, Zucknick M, Caudron-Herger M, Oakes C, Fleig V, Keklikoglou I, Allegra D, Serra L, Thakurela S, ... ... Plass C, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. Plos Genetics. 9: e1003373. PMID 23593011 DOI: 10.1371/journal.pgen.1003373  0.4
2013 Hsu SH, Motiwala T, Roy S, Claus R, Mustafa M, Plass C, Freitas MA, Ghoshal K, Jacob ST. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate. Journal of Cellular Biochemistry. 114: 1810-8. PMID 23533167 DOI: 10.1002/jcb.24525  0.4
2013 Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, Wuttig D, Warnatz HJ, Stehr H, Rausch T, Jäger N, Gu L, Bogatyrova O, Stütz AM, Claus R, ... ... Plass C, et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell. 23: 159-70. PMID 23410972 DOI: 10.1016/j.ccr.2013.01.002  0.4
2013 Wei QX, Claus R, Hielscher T, Mertens D, Raval A, Oakes CC, Tanner SM, de la Chapelle A, Byrd JC, Stilgenbauer S, Plass C. Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia. Plos One. 8: e55261. PMID 23383130 DOI: 10.1371/journal.pone.0055261  0.4
2013 Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer PS, Schumacher U, Grupp K, Izbicki JR, Pantel K, Dikomey E, Korbel JO, Plass C, et al. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 975-83. PMID 23370768 DOI: 10.1038/modpathol.2012.236  0.4
2013 Haas J, Frese KS, Park YJ, Keller A, Vogel B, Lindroth AM, Weichenhan D, Franke J, Fischer S, Bauer A, Marquart S, Sedaghat-Hamedani F, Kayvanpour E, Köhler D, Wolf NM, ... ... Plass C, et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. Embo Molecular Medicine. 5: 413-29. PMID 23341106 DOI: 10.1002/emmm.201201553  0.4
2013 Baer C, Claus R, Plass C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Research. 73: 473-7. PMID 23316035 DOI: 10.1158/0008-5472.CAN-12-3731  0.4
2013 Sonnet M, Baer C, Rehli M, Weichenhan D, Plass C. Enrichment of methylated DNA by methyl-CpG immunoprecipitation. Methods in Molecular Biology (Clifton, N.J.). 971: 201-12. PMID 23296965 DOI: 10.1007/978-1-62703-269-8_11  0.4
2013 Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Kreahling J, Plass C, Smiraglia DJ, Tockman MS, Kim SJ. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer (Amsterdam, Netherlands). 79: 198-204. PMID 23273563 DOI: 10.1016/j.lungcan.2012.11.019  0.4
2013 Faber K, Bullinger L, Ragu C, Garding A, Mertens D, Miller C, Martin D, Walcher D, Döhner K, Döhner H, Claus R, Plass C, Sykes SM, Lane SW, Scholl C, et al. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling. The Journal of Clinical Investigation. 123: 299-314. PMID 23202735 DOI: 10.1172/JCI64745  0.4
2013 Claus R, Pfeifer D, Almstedt M, Zucknick M, Hackanson B, Plass C, Lübbert M. Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia. Leukemia Research. 37: 190-6. PMID 23158571 DOI: 10.1016/j.leukres.2012.10.015  0.4
2013 Scherf DB, Sarkisyan N, Jacobsson H, Claus R, Bermejo JL, Peil B, Gu L, Muley T, Meister M, Dienemann H, Plass C, Risch A. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene. 32: 3329-38. PMID 22945651 DOI: 10.1038/onc.2012.344  0.4
2012 Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, ... ... Plass C, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 22: 425-37. PMID 23079654 DOI: 10.1016/j.ccr.2012.08.024  0.4
2012 Faryna M, Konermann C, Aulmann S, Bermejo JL, Brugger M, Diederichs S, Rom J, Weichenhan D, Claus R, Rehli M, Schirmacher P, Sinn HP, Plass C, Gerhauser C. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4937-50. PMID 22930747 DOI: 10.1096/fj.12-209502  0.4
2012 Börno ST, Fischer A, Kerick M, Fälth M, Laible M, Brase JC, Kuner R, Dahl A, Grimm C, Sayanjali B, Isau M, Röhr C, Wunderlich A, Timmermann B, Claus R, ... Plass C, et al. Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discovery. 2: 1024-35. PMID 22930729 DOI: 10.1158/2159-8290.CD-12-0041  0.4
2012 Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch CP, Herpel E, Rehli M, Byrd JC, Wendtner CM, Plass C. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Research. 72: 3775-85. PMID 22710432 DOI: 10.1158/0008-5472.CAN-12-0803  0.4
2012 Claus R, Wilop S, Hielscher T, Sonnet M, Dahl E, Galm O, Jost E, Plass C. A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR. Epigenetics. 7: 772-80. PMID 22647397 DOI: 10.4161/epi.20299  0.4
2012 Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu L, Zucknick M, Mertens D, Bühler A, Oakes CC, Larson RA, Kay NE, Jelinek DF, Kipps TJ, Rassenti LZ, Gribben JG, ... ... Plass C, et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2483-91. PMID 22564988 DOI: 10.1200/JCO.2011.39.3090  0.4
2012 Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Bermejo JL, Herold-Mende C, Plass C, Schmezer P. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma. Oncogene. 31: 5108-16. PMID 22286769 DOI: 10.1038/onc.2011.660  0.4
2012 Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tönjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, ... ... Plass C, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 482: 226-31. PMID 22286061 DOI: 10.1038/nature10833  0.4
2012 Campos B, Warta R, Chaisaingmongkol J, Geiselhart L, Popanda O, Hartmann C, von Deimling A, Unterberg A, Plass C, Schmezer P, Herold-Mende C. Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas. International Journal of Cancer. Journal International Du Cancer. 131: 1963-8. PMID 22275178 DOI: 10.1002/ijc.27446  0.4
2012 Claus R, Hackanson B, Poetsch AR, Zucknick M, Sonnet M, Blagitko-Dorfs N, Hiller J, Wilop S, Brümmendorf TH, Galm O, Platzbecker U, Byrd JC, Döhner K, Döhner H, Lübbert M, ... Plass C, et al. Quantitative analyses of DAPK1 methylation in AML and MDS. International Journal of Cancer. Journal International Du Cancer. 131: E138-42. PMID 21918973 DOI: 10.1002/ijc.26429  0.4
2011 Gast A, Bermejo JL, Claus R, Brandt A, Weires M, Weber A, Plass C, Sucker A, Hemminki K, Schadendorf D, Kumar R. Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. Plos One. 6: e24370. PMID 21931695 DOI: 10.1371/journal.pone.0024370  0.4
2011 Arab K, Smith LT, Gast A, Weichenhan D, Huang JP, Claus R, Hielscher T, Espinosa AV, Ringel MD, Morrison CD, Schadendorf D, Kumar R, Plass C. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. Carcinogenesis. 32: 1467-73. PMID 21771727 DOI: 10.1093/carcin/bgr138  0.4
2011 Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nature Genetics. 43: 513-8. PMID 21614091 DOI: 10.1038/ng.840  0.4
2011 Park YJ, Claus R, Weichenhan D, Plass C. Genome-wide epigenetic modifications in cancer. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. ProgrèS Des Recherches Pharmaceutiques. 67: 25-49. PMID 21141723 DOI: 10.1007/978-3-7643-8989-5_2  0.4
2011 Chen SS, Claus R, Lucas DM, Yu L, Qian J, Ruppert AS, West DA, Williams KE, Johnson AJ, Sablitzky F, Plass C, Byrd JC. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood. 117: 862-71. PMID 21098398 DOI: 10.1182/blood-2010-05-284638  0.4
2011 Frenzel LP, Claus R, Plume N, Schwamb J, Konermann C, Pallasch CP, Claasen J, Brinker R, Wollnik B, Plass C, Wendtner CM. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus. International Journal of Cancer. Journal International Du Cancer. 128: 2495-500. PMID 20669229 DOI: 10.1002/ijc.25579  0.4
2010 Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi A, Gdynia G, Penzel R, Longerich T, Breuhahn K, Popanda O, ... Plass C, et al. Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms Hepatology. 52: 2023-2033. PMID 20979053 DOI: 10.1002/hep.23939  0.4
2010 Claus R, Plass C, Armstrong SA, Bullinger L. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights. Future Oncology (London, England). 6: 1415-31. PMID 20919827 DOI: 10.2217/fon.10.110  0.4
2010 Ghosh S, Yates AJ, Frühwald MC, Miecznikowski JC, Plass C, Smiraglia D. Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues. Epigenetics : Official Journal of the Dna Methylation Society. 5: 527-38. PMID 20505344 DOI: 10.4161/epi.5.6.12228  0.4
2010 Blum KA, Liu Z, Lucas DM, Chen P, Xie Z, Baiocchi R, Benson DM, Devine SM, Jones J, Andritsos L, Flynn J, Plass C, Marcucci G, Chan KK, Grever MR, et al. Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation. British Journal of Haematology. 150: 189-95. PMID 20456354 DOI: 10.1111/j.1365-2141.2010.08213.x  0.4
2010 Ghoshal K, Motiwala T, Claus R, Yan P, Kutay H, Datta J, Majumder S, Bai S, Majumder A, Huang T, Plass C, Jacob ST. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors. Plos One. 5: e10338. PMID 20454457 DOI: 10.1371/journal.pone.0010338  0.4
2009 Chen SS, Sherman MH, Hertlein E, Johnson AJ, Teitell MA, Byrd JC, Plass C. Epigenetic alterations in a murine model for chronic lymphocytic leukemia. Cell Cycle (Georgetown, Tex.). 8: 3663-7. PMID 19901553 DOI: 10.4161/cc.8.22.9957  0.4
2009 Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, Kutsch N, Krause G, Mayr C, Rosenwald A, Plass C, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 114: 3255-64. PMID 19692702 DOI: 10.1182/blood-2009-06-229898  0.4
2009 Chen SS, Raval A, Johnson AJ, Hertlein E, Liu TH, Jin VX, Sherman MH, Liu SJ, Dawson DW, Williams KE, Lanasa M, Liyanarachchi S, Lin TS, Marcucci G, Pekarsky Y, ... ... Plass C, et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 106: 13433-8. PMID 19666576 DOI: 10.1073/pnas.0906455106  0.4
2009 Liu Z, Wu J, Xie Z, Liu S, Fan-Havard P, Huang TH, Plass C, Marcucci G, Chan KK. Quantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry. Analytical Biochemistry. 391: 106-13. PMID 19442645 DOI: 10.1016/j.ab.2009.05.012  0.4
2009 Yu J, Ershler M, Yu L, Wei M, Hackanson B, Yokohama A, Mitsui T, Liu C, Mao H, Liu S, Liu Z, Trotta R, Liu CG, Liu X, Huang K, ... ... Plass C, et al. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. Blood. 113: 5558-67. PMID 19329776 DOI: 10.1182/blood-2009-02-205732  0.4
2009 Liu Z, Liu S, Xie Z, Pavlovicz RE, Wu J, Chen P, Aimiuwu J, Pang J, Bhasin D, Neviani P, Fuchs JR, Plass C, Li PK, Li C, Huang TH, et al. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. The Journal of Pharmacology and Experimental Therapeutics. 329: 505-14. PMID 19201992 DOI: 10.1124/jpet.108.147934  0.4
2009 Jun P, Hong C, Lal A, Wong JM, McDermott MW, Bollen AW, Plass C, Held WA, Smiraglia DJ, Costello JF. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Neuro-Oncology. 11: 414-22. PMID 19001526 DOI: 10.1215/15228517-2008-096  0.4
2009 Costello JF, Hong C, Plass C, Smiraglia DJ. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis. Methods in Molecular Biology (Clifton, N.J.). 507: 131-48. PMID 18987812 DOI: 10.1007/978-1-59745-522-0_11  0.4
2008 Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T, Yu L, Liu C, Bloomfield CD, Marcucci G, Plass C, et al. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood. 112: 2013-6. PMID 18566324 DOI: 10.1182/blood-2008-01-128595  0.4
2008 Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, Chen SS, Blagitko-Dorfs N, Maharry K, Whitman SP, Schmittgen TD, Lübbert M, Marcucci G, Bloomfield CD, Plass C. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Research. 68: 3142-51. PMID 18451139 DOI: 10.1158/0008-5472.CAN-08-0483  0.4
2008 Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Research. 68: 2489-97. PMID 18381458 DOI: 10.1158/0008-5472.CAN-07-3194  0.4
2007 Smiraglia DJ, Kazhiyur-Mannar R, Oakes CC, Wu YZ, Liang P, Ansari T, Su J, Rush LJ, Smith LT, Yu L, Liu C, Dai Z, Chen SS, Wang SH, Costello J, ... ... Plass C, et al. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations. Bmc Genomics. 8: 446. PMID 18053125 DOI: 10.1186/1471-2164-8-446  0.4
2007 Smith JF, Mahmood S, Song F, Morrow A, Smiraglia D, Zhang X, Rajput A, Higgins MJ, Krumm A, Petrelli NJ, Costello JF, Nagase H, Plass C, Held WA. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer. Epigenetics. 2: 161-72. PMID 17965620  0.4
2007 Smith LT, Otterson GA, Plass C. Unraveling the epigenetic code of cancer for therapy. Trends in Genetics : Tig. 23: 449-56. PMID 17681396 DOI: 10.1016/j.tig.2007.07.005  0.4
2007 Blum W, Klisovic RB, Hackanson B, Liu Z, Liu S, Devine H, Vukosavljevic T, Huynh L, Lozanski G, Kefauver C, Plass C, Devine SM, Heerema NA, Murgo A, Chan KK, et al. Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3884-91. PMID 17679729 DOI: 10.1200/JCO.2006.09.4169  0.4
2007 Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, Lin TS, Kipps TJ, Murray F, Weisenburger D, Sanger W, ... ... Plass C, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 129: 879-90. PMID 17540169 DOI: 10.1016/j.cell.2007.03.043  0.4
2007 Wu J, Wang SH, Potter D, Liu JC, Smith LT, Wu YZ, Huang TH, Plass C. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. Bmc Genomics. 8: 131. PMID 17524140 DOI: 10.1186/1471-2164-8-131  0.4
2007 Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Research. 67: 4657-64. PMID 17510391 DOI: 10.1158/0008-5472.CAN-06-4793  0.4
2007 Allegrucci C, Wu YZ, Thurston A, Denning CN, Priddle H, Mummery CL, Ward-van Oostwaard D, Andrews PW, Stojkovic M, Smith N, Parkin T, Jones ME, Warren G, Yu L, Brena RM, ... Plass C, et al. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Human Molecular Genetics. 16: 1253-68. PMID 17409196 DOI: 10.1093/hmg/ddm074  0.4
2007 Brena RM, Morrison C, Liyanarachchi S, Jarjoura D, Davuluri RV, Otterson GA, Reisman D, Glaros S, Rush LJ, Plass C. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. Plos Medicine. 4: e108. PMID 17388669 DOI: 10.1371/journal.pmed.0040108  0.36
2007 Dawson DW, Hong JS, Shen RR, French SW, Troke JJ, Wu YZ, Chen SS, Gui D, Regelson M, Marahrens Y, Morse HC, Said J, Plass C, Teitell MA. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene. 26: 4243-52. PMID 17260020 DOI: 10.1038/sj.onc.1210211  0.4
2006 Brena RM, Auer H, Kornacker K, Plass C. Quantification of DNA methylation in electrofluidics chips (Bio-COBRA). Nature Protocols. 1: 52-8. PMID 17406211 DOI: 10.1038/nprot.2006.8  0.4
2006 Brena RM, Plass C, Costello JF. Mining methylation for early detection of common cancers Plos Medicine. 3: 2184-2185. PMID 17194184 DOI: 10.1371/journal.pmed.0030479  0.4
2006 Plass C, Smiraglia DJ. Genome-wide analysis of DNA methylation changes in human malignancies Current Topics in Microbiology and Immunology. 310: 179-198. PMID 16909911 DOI: 10.1007/3-540-31181-5_9  0.4
2006 Wu J, Smith LT, Plass C, Huang TH. ChIP-chip comes of age for genome-wide functional analysis. Cancer Research. 66: 6899-902. PMID 16849531 DOI: 10.1158/0008-5472.CAN-06-0276  0.4
2006 Smith LT, Mayerson J, Nowak NJ, Suster D, Mohammed N, Long S, Auer H, Jones S, McKeegan C, Young G, Bos G, Plass C, Morrison C. 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome. Genes, Chromosomes & Cancer. 45: 957-66. PMID 16847944 DOI: 10.1002/gcc.20354  0.4
2006 Kazhiyur-Mannar R, Smiraglia DJ, Plass C, Wenger R. Contour area filtering of two-dimensional electrophoresis images. Medical Image Analysis. 10: 353-65. PMID 16531098 DOI: 10.1016/j.media.2006.01.004  0.4
2006 Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. DNA motifs associated with aberrant CpG island methylation. Genomics. 87: 572-9. PMID 16487676 DOI: 10.1016/j.ygeno.2005.12.016  0.4
2006 Brena RM, Auer H, Kornacker K, Hackanson B, Raval A, Byrd JC, Plass C. Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform. Nucleic Acids Research. 34: e17. PMID 16464820 DOI: 10.1093/nar/gnj017  0.4
2006 Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, Leu YW, Chan MW, Plass C, Nephew KP, Davuluri RV, Huang TH. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Molecular Cell. 21: 393-404. PMID 16455494 DOI: 10.1016/j.molcel.2005.12.016  0.4
2006 Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, Otterson GA, Morrison CD, Smiraglia DJ, Plass C. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proceedings of the National Academy of Sciences of the United States of America. 103: 982-7. PMID 16415157 DOI: 10.1073/pnas.0510171102  0.4
2006 Rosenbauer F, Owens BM, Yu L, Tumang JR, Steidl U, Kutok JL, Clayton LK, Wagner K, Scheller M, Iwasaki H, Liu C, Hackanson B, Akashi K, Leutz A, Rothstein TL, ... Plass C, et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nature Genetics. 38: 27-37. PMID 16311598 DOI: 10.1038/ng1679  0.4
2006 Lin M, Smith LT, Smiraglia DJ, Kazhiyur-Mannar R, Lang JC, Schuller DE, Kornacker K, Wenger R, Plass C. DNA copy number gains in head and neck squamous cell carcinoma. Oncogene. 25: 1424-33. PMID 16247453 DOI: 10.1038/sj.onc.1209166  0.4
2005 Raval A, Lucas DM, Matkovic JJ, Bennett KL, Liyanarachchi S, Young DC, Rassenti L, Kipps TJ, Grever MR, Byrd JC, Plass C. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3877-85. PMID 15809452 DOI: 10.1200/JCO.2005.02.196  0.4
2005 Whitman SP, Liu S, Vukosavljevic T, Rush LJ, Yu L, Liu C, Klisovic MI, Maharry K, Guimond M, Strout MP, Becknell B, Dorrance A, Klisovic RB, Plass C, Bloomfield CD, et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood. 106: 345-52. PMID 15774615 DOI: 10.1182/blood-2005-01-0204  0.4
2005 Liu S, Shen T, Huynh L, Klisovic MI, Rush LJ, Ford JL, Yu J, Becknell B, Li Y, Liu C, Vukosavljevic T, Whitman SP, Chang KS, Byrd JC, Perrotti D, ... Plass C, et al. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Research. 65: 1277-84. PMID 15735013 DOI: 10.1158/0008-5472.CAN-04-4532  0.4
2005 Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ, Raval A, Liu TH, Ding W, Mao C, Liu S, Smith LT, Lee S, Rassenti L, Marcucci G, ... ... Plass C, et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genetics. 37: 265-74. PMID 15723065 DOI: 10.1038/ng1521  0.4
2005 Huang THM, Plass C, Liang G, Laird PW. Epi meets genomics: Technologies for finding and reading the 5th base The Epigenome: Molecular Hide and Seek. 39-64. DOI: 10.1002/3527601511.ch3  0.4
2004 Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Davuluri RV, Plass C, Nephew KP, Huang TH. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Research. 64: 8184-92. PMID 15548683 DOI: 10.1158/0008-5472.CAN-04-2045  0.4
2004 Yu L, Liu C, Bennett K, Wu YZ, Dai Z, Vandeusen J, Opavsky R, Raval A, Trikha P, Rodriguez B, Becknell B, Mao C, Lee S, Davuluri RV, Leone G, ... ... Plass C, et al. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics. 84: 647-60. PMID 15475242 DOI: 10.1016/j.ygeno.2004.06.010  0.36
2004 Dai Z, Popkie AP, Zhu WG, Timmers CD, Raval A, Tannehill-Gregg S, Morrison CD, Auer H, Kratzke RA, Niehans G, Amatschek S, Sommergruber W, Leone GW, Rosol T, Otterson GA, ... Plass C, et al. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene. 23: 3521-9. PMID 15116090 DOI: 10.1038/sj.onc.1207441  0.4
2004 Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, Bembea M, Liu TH, Heerema NA, Rassenti L, Liyanarachchi S, Davuluri R, Byrd JC, Plass C. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Research. 64: 2424-33. PMID 15059895 DOI: 10.1158/0008-5472.CAN-03-2870  0.4
2004 Zhu WG, Hileman T, Ke Y, Wang P, Lu S, Duan W, Dai Z, Tong T, Villalona-Calero MA, Plass C, Otterson GA. 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation. The Journal of Biological Chemistry. 279: 15161-6. PMID 14722112 DOI: 10.1074/jbc.M311703200  0.36
2004 Smith LT, Plass C. DNA methylation leaves its mark in head and neck squamous cell carcinomas (HNSCC) Current Genomics. 5: 489-498. DOI: 10.2174/1389202043348940  0.4
2003 Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. Predicting aberrant CpG island methylation Proceedings of the National Academy of Sciences of the United States of America. 100: 12253-12258. PMID 14519846 DOI: 10.1073/pnas.2037852100  0.4
2003 Li J, Zhang Z, Dai Z, Popkie AP, Plass C, Morrison C, Wang Y, You M. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia (New York, N.Y.). 5: 362-6. PMID 14511407 DOI: 10.1016/S1476-5586(03)80029-5  0.36
2003 Motiwala T, Ghoshal K, Das A, Majumder S, Weichenhan D, Wu YZ, Holman K, James SJ, Jacob ST, Plass C. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene. 22: 6319-31. PMID 14508512 DOI: 10.1038/sj.onc.1206750  0.4
2003 Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Molecular and Cellular Biology. 23: 4056-65. PMID 12773551  0.36
2003 Smiraglia DJ, Plass C. The development of CpG island methylation biomarkers using restriction landmark genomic scanning. Annals of the New York Academy of Sciences. 983: 110-9. PMID 12724216  0.4
2003 Dai Z, Zhu WG, Morrison CD, Brena RM, Smiraglia DJ, Raval A, Wu YZ, Rush LJ, Ross P, Molina JR, Otterson GA, Plass C. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Human Molecular Genetics. 12: 791-801. PMID 12651874 DOI: 10.1093/hmg/ddg083  0.4
2003 Li J, Zhang Z, Dai Z, Plass C, Morrison C, Wang Y, Wiest JS, Anderson MW, You M. LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer. Oncogene. 22: 1243-6. PMID 12606951 DOI: 10.1038/sj.onc.1206192  0.36
2003 Klisovic MI, Maghraby EA, Parthun MR, Guimond M, Sklenar AR, Whitman SP, Chan KK, Murphy T, Anon J, Archer KJ, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G. Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells Leukemia. 17: 350-358. PMID 12592335 DOI: 10.1038/sj.leu.2402776  0.4
2003 Oakes CC, Smiraglia DJ, Plass C, Trasler JM, Robaire B. Aging results in hypermethylation of ribosomal DNA in sperm and liver of male rats. Proceedings of the National Academy of Sciences of the United States of America. 100: 1775-80. PMID 12574505 DOI: 10.1073/pnas.0437971100  0.4
2003 Smiraglia DJ, Smith LT, Lang JC, Rush LJ, Dai Z, Schuller DE, Plass C. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). Journal of Medical Genetics. 40: 25-33. PMID 12525538  0.4
2002 Dai Z, Weichenhan D, Wu YZ, Hall JL, Rush LJ, Smith LT, Raval A, Yu L, Kroll D, Muehlisch J, Frühwald MC, de Jong P, Catanese J, Davuluri RV, Smiraglia DJ, ... Plass C, et al. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands. Genome Research. 12: 1591-8. PMID 12368252 DOI: 10.1101/gr.197402  0.4
2002 Rush LJ, Plass C. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Analytical Biochemistry. 307: 191-201. PMID 12202234 DOI: 10.1016/S0003-2697(02)00033-7  0.36
2002 Smiraglia DJ, Plass C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene. 21: 5414-26. PMID 12154404 DOI: 10.1038/sj.onc.1205608  0.4
2002 Rush LJ, Plass C. Alterations of DNA methylation in hematologic malignancies. Cancer Letters. 185: 1-12. PMID 12142073 DOI: 10.1016/S0304-3835(02)00288-4  0.36
2002 Costello JF, Smiraglia DJ, Plass C. Restriction landmark genome scanning. Methods (San Diego, Calif.). 27: 144-9. PMID 12095273 DOI: 10.1016/S1046-2023(02)00067-1  0.4
2002 Smiraglia DJ, Szymanska J, Kraggerud SM, Lothe RA, Peltomäki P, Plass C. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene. 21: 3909-16. PMID 12032829 DOI: 10.1038/sj.onc.1205488  0.4
2002 Moinova HR, Chen WD, Shen L, Smiraglia D, Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, Minna J, Willson JK, Green SB, Issa JP, Markowitz SD. HLTF gene silencing in human colon cancer. Proceedings of the National Academy of Sciences of the United States of America. 99: 4562-7. PMID 11904375 DOI: 10.1073/pnas.062459899  0.4
2002 Rush LJ, Heinonen K, Mrózek K, Wolf BJ, Abdel-Rahman M, Szymanska J, Peltomäki P, Kapadia F, Bloomfield CD, Caligiuri MA, Plass C. Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line. Blood. 99: 1874-6. PMID 11871388 DOI: 10.1182/blood.V99.5.1874  0.4
2002 Majumder S, Ghoshal K, Datta J, Bai S, Dong X, Quan N, Plass C, Jacob ST. Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma. The Journal of Biological Chemistry. 277: 16048-58. PMID 11844796 DOI: 10.1074/jbc.M111662200  0.4
2002 Yoon BJ, Herman H, Sikora A, Smith LT, Plass C, Soloway PD. Regulation of DNA methylation of Rasgrf1. Nature Genetics. 30: 92-6. PMID 11753386 DOI: 10.1038/ng795  0.4
2001 Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene. 20: 7787-96. PMID 11753657 DOI: 10.1038/sj.onc.1204970  0.36
2001 Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K, Mrózek K, Sill H, Knuutila S, Kolitz JE, Archer KJ, Caligiuri MA, Bloomfield CD, de La Chapelle A. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13901-6. PMID 11707601 DOI: 10.1073/pnas.241525498  0.4
2001 Dai Z, Lakshmanan RR, Zhu WG, Smiraglia DJ, Rush LJ, Frühwald MC, Brena RM, Li B, Wright FA, Ross P, Otterson GA, Plass C. Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia (New York, N.Y.). 3: 314-23. PMID 11571631 DOI: 10.1038/sj/neo/7900162  0.4
2001 Frühwald MC, O'Dorisio MS, Smith L, Dai Z, Wright FA, Paulus W, Jürgens H, Plass C. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan]. Klinische PäDiatrie. 213: 197-203. PMID 11528554 DOI: 10.1055/s-2001-16851  0.4
2001 Frühwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X, Wright FA, Plass C. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility. Oncogene. 20: 5033-42. PMID 11526488 DOI: 10.1038/sj.onc.1204613  0.4
2001 Smiraglia DJ, Rush LJ, Frühwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies Human Molecular Genetics. 10: 1413-1419. PMID 11440994 DOI: 10.1093/hmg/10.13.1413  0.4
2001 Frühwald MC, O'Dorisio MS, Dai Z, Rush LJ, Krahe R, Smiraglia DJ, Pietsch T, Elsea SH, Plass C. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes, Chromosomes & Cancer. 30: 38-47. PMID 11107174 DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1052>3.0.CO;2-S  0.36
2000 Costello JF, Plass C, Cavenee WK. Aberrant methylation of genes in low-grade astrocytomas. Brain Tumor Pathology. 17: 49-56. PMID 11210171  0.4
2000 Frühwald MC, O'Dorisio MS, Rush LJ, Reiter JL, Smiraglia DJ, Wenger G, Costello JF, White PS, Krahe R, Brodeur GM, Plass C. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon. Journal of Medical Genetics. 37: 501-9. PMID 10882752 DOI: 10.1136/jmg.37.7.501  0.4
2000 Zhou XP, Smith WM, Gimm O, Mueller E, Gao X, Sarraf P, Prior TW, Plass C, von Deimling A, Black PM, Yates AJ, Eng C. Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population. Journal of Medical Genetics. 37: 410-4. PMID 10851250 DOI: 10.1136/JMG.37.6.410  0.4
2000 Ying AK, Hassanain HH, Roos CM, Smiraglia DJ, Issa JPJ, Michler RE, Caligiuri M, Plass C, Goldschmidt-Clermont PJ. Methylation of the estrogen receptor-α gene promoter is selectively increased in proliferating human aortic smooth muscle cells Cardiovascular Research. 46: 172-179. PMID 10727665 DOI: 10.1016/S0008-6363(00)00004-3  0.4
2000 Costello JF, Frühwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomäki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, ... ... Plass C, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genetics. 24: 132-8. PMID 10655057 DOI: 10.1038/72785  0.4
1999 Smiraglia DJ, Frühwald MC, Costello JF, McCormick SP, Dai Z, Peltomäki P, O'Dorisio MS, Cavenee WK, Plass C. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics. 58: 254-62. PMID 10373323 DOI: 10.1006/geno.1999.5840  0.4
1997 Plass C, Weichenhan D, Catanese J, Costello JF, Yu F, Yu L, Smiraglia D, Cavenee WK, Caligiuri MA, deJong P, Held WA. An arrayed human not I-EcoRV boundary library as a tool for RLGS spot analysis. Dna Research : An International Journal For Rapid Publication of Reports On Genes and Genomes. 4: 253-5. PMID 9330914  0.4
Show low-probability matches.